Campylobacter

The genus Campylobacter are Gram-negative, spiral, microaerophilic bacteria. Motile, with either uni- or bi-polar flagella, the organisms have a somewhat curved, rod-like appearance, and are oxidase-positive. Campylobacter jejuni is now recognisedas one of the main causes of bacterial foodbornedisease in many developed countries. At least a dozen species of Campylobacter have been implicated in human disease, with C. jejuni and C. coli the most common. (From the Wikpedia article Campylobacter.)

Download PDF

Recent Publications on Campylobacter:
Characterization of CetA and CetB, a bipartite energy taxis system in Campylobacter jejuni. The energy taxis receptor Aer, in Escherichia coli, senses changes in the...	18th July, 2008	Department of Microbiology and Immunology, University of Michigan, Ann	Mol Microbiol. 2008 Jul 7;. DOI Direct Link
Microarray analysis of campylobacter jejuni: to the guts of the problem! The energy taxis receptor Aer, in Escherichia coli, senses changes in the...	17th July, 2008	Department of Infectious and Tropical Diseases London School of Hygiene	Comp Funct Genomics. 2002;3(4):338-41. DOI Direct Link
Combined treatment with oral kanamycin and parenteral antibiotics for a case of persistent bacteremia and intestinal carriage with Campylobacter coli. Campylobacter coli (C. coli) is a rare pathogen of bacteremia, but in...	17th July, 2008	Department of Infectious Diseases, Graduate School of Medicine, The	Intern Med. 2008;47(14):1363-6. Epub 2008 Jul 15.
Is irritable bowel syndrome an inflammatory disorder? Histopathologic data demonstrate low-grade mucosal inflammation in a...	17th July, 2008	Department of Internal Medicine and Gastroenterology, Building #5 (Nuove	Curr Gastroenterol Rep. 2008 Aug;10(4):385-90.
Topology and patch-clamp analysis of the sodium channel in relationship to the anti-lipid a antibody in campylobacteriosis. An infecting strain VLA2/18 of Campylobacter jejuni was obtained from an...	16th July, 2008	Institute of Molecular Medicine and Genetics, Medical College of Georgia,	J Neurosci Res. 2008 Jul 14;. DOI Direct Link
→View more research publications.

BioNews Results for Campylobacter:
Optimer Pharmaceuticals Announces Positive Results In Prulifloxacin Phase 3 Study	Pharmaceutical Online:  Jul 17 2008 1:24PM Matching: campylobacter
UK smallcap opening - Angel Biotechnology hardens on milestone payment	Interactive Investor International:  Jul 17 2008 8:19AM Matching: campylobacter
Optimer Pharmaceuticals Announces Positive Results in Prulifloxacin Phase 3 Study	Yahoo!:  Jul 16 2008 1:01PM Matching: campylobacter
High Growth Reported for the World Food Safety Testing Market	Canadian Business Magazine:  Jul 2 2008 9:49AM Matching: campylobacter
High Growth Reported for the World Food Safety Testing Market	Street Insider:  Jul 2 2008 9:48AM Matching: campylobacter
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Campylobacter Clinical Trials:
Campylobacter Jejuni Challenge Model Development: Dose Ranging Study	Campylobacter Infections

Campylobacter Patents:
US Patent No.	Title
7371393	Methods for reducing fecal shedding
7381406	Probiotic lactobacillus strains for pets
7381439	Method and composition for washing poultry during processing
7381525	AC/DC voltage apparatus for detection of nucleic acids
7381533	Electrodes linked via oligomers to nucleic acids
→View more patents.

Companies working in the area of Campylobacter from Bioportfolio's Biocorporate database :
Company Name
Kim Laboratories Kim Laboratoriesis currently funded by a consortium of investors and focused on development and production of innovative detection system based on laser/optic technology. Our proprietary reagents are... www.kimlaboratories.com/        View full profile

BioPortfolio Ltd. offers e-mail and postal lists for Campylobacter scientists - we have details of around 1050 individuals working on Campylobacter .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.